Greer Capital Advisors
We specialize in bridging the equity gap for late and growth-stage companies in our area to build and realize value.
more
>
3.30.09
Drilled to the Bone - Vidacare
3.11.09
Tranzyme Pharma Announces Issuance of Three New Patents Further Strengthening Company's Advanced Ghrelin Agonist Programs
2.24.09
Vaxin Completes Enrollment in Pandemic Bird Flu Vaccine Study
February 2009
More Than Skin Deep - Vaxin
2.6.09
Medical Technology Firm Vidacare is Expanding its Global Reach
2.2.09
Something Fishy in Steelers' diet aids cardiovascular health
1.31.09
Despite the Quiet, Cumberland Hints at Growth
12.22.08
TransMolecular Receives Orphan Drug Designation for 131I-TM601 for the Treatment of Melanoma
12.19.08
Cumberland wins approval for updated labeling of Acetadote injection
Fall 2008
Expression Genetics: Targeting Cancer - Rocket City thought process leads to a promising new cancer therapy delivery system
10.6.08
Emerging Drug Developer: Transmolecular
9.29.08
The 2008 Technology Innovation Awards: Vidacare
9.28.08
Synthetic venom shows real promise on tumors
8.1.08
FoodSource Lure gets grant to create Lyme vaccine bait
7.22.08
Tranzyme Pharma Receives Notices of Allowance from USPTO on Two Patents
6.17.08
Transmolecular Presents Imaging and Pharmacokinetic Analysis of Iodine-TM601 at Society for Nuclear Medicine Meeting
6.05.08
Tranzyme Pharma to Present "Ghrelin Agonist (TZP-101) Effects on Patients with Severe Symptomatic Diabetic Gastroparesis at ADA 2008
6.02.08
Transmolecular Reports Positive Results from Phase I Trial of Iodine-TM601 in Metastatic Melanoma
5.30.08
Transmolecular Initiates Phase I Clinical Trial for Unlabeled TM601 in Recurrent Malignant Glioma
5.19.08
Vidacare unveils next generation emergency tool for military medics
5.13.08
Vidacare: New device made Hendershot's dream of organ donation possible
May 2008
Behavioral Health: Extending benefits to mental health
4.14.08
TransMolecular Unveils First Data on TM601 Anti-Angiogenic Mechanism-of-Action at AACR Annual Meeting
3.19.08
University teams vie for tech funding
3.11.08
Brookwood Pharmaceuticals, Inc.: Drug maker banks on city
3.3.08
De Moines medical school training students on Vidacare's system
2.21.08
VectorLogics Inc. receives tech grant from University of Maryland
1.8.08
Emory University training future doctors on Vidacare's medical technology
1.7.08
Transmolecular Receives Orphan Drug Designation for Non-radiolabeled TM601 for the Treatment of Malignant Glioma
12.10.07
UTHSC spinoff CardioSpectra sold
12.10.07
Volcano announces plan to acquire CardioSpectra
12.7.07
FDA approves Vidacare's new biopsy system for the market
11.19.07
Transmolecular Reports Positive Phase 2 Data
11.1.07
Tranzyme Pharma Closes New $20 Million Financing
10.30.07
Tranzyme Initiates Dosing of Patients in a Multi-National Phase IIb Clinical Trial for the Treatment of Severe Gastroparesis
10.24.07
Tranzyme Pharma's Motilin Antagonist TZP-201 Shows Potential for Preventing and Treating Chemotherapy-Induced Diarrhea (CID)
9.12.07
Innovation Depot Signs 8 New Clients To Tech Stable
9.5.07
The Molecular Profiling Institute Launches Mammostrat (TM) - A Novel, Molecular-Targeted, Prognostic Test for Breast Cancer Patients
8.1.07
Brookwood Pharmaceuticals Acquired by SurModics for $62 Million
7.26.07
Tranzyme initiates dosing of patients in a multi-national phase IIb clinical trial with its TZP-101
7.24.07
Cumberland Pharmaceuticals Prices IPO
7.23.07
Vidacare: Paramedic protocol that local department pioneered has been adopted across Alabama
7.22.07
Predicting cancer's return
7.13.07
Fishing World Grows Greener
6.18.07
New Biomedical Device Company, Aeon Bioscience, Inc., Launches in Birmingham
5.24.07
Foodsource Lures: Add food mimics to your bait menu
5.7.07
Brookwood Pharmaceuticals, Targeted Technology Ventures Form New Company to Improve Cardiac Stents
5.2.07
Alabama Development Office Named Best in U.S.
4.24.07
Cumberland Pharmaceuticals Offers Alternative to Zelnorm
more headlines...
© 2003 Greer Capital Advisors LLC
